Jayne Parker - Profile and Investment Details

Investor Profile

Jayne Parker is a Venture Capital, Angel Group, Private Equity Firm based in Cambridge, England, United Kingdom with a diverse investment portfolio that includes companies such as Phico Therapeutics, Porotech, PneumaCare, Spectral Edge, Arquer Diagnostics, The CCG Trust, Nujira, OBRIZUM Group Ltd.Lightpoint Medical, Definigen, Ubisense, SwiftKey, Cambridge GaN Devices, Featurespace, Metalysis, Augmentra, Cambridge Communication Systems, Camrivox, SupaPass, Enval, Kaptivo, Sorex Sensors, Eagle Genomics, Arachnys, . Over time, Jayne Parker has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jayne Parker is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Clean Tech, Health Care, High-growth Startups, E-commerce, Payments, Wellness, Investment Management, Design, Intelligent Systems, Angel Investment, Chemical, Portfolio Management, Medical Technologies, Banking, Education, Artificial Intelligence (AI), Tech, Information Technology (IT), Analytics, Due Diligence Services, Technology, Finance, Software, Biotechnology, FinTech, Consulting, B2C, Hardware, UK Startups, Web Development, Developer Tools, Medical, SaaS, Sensors, Information Technology, B2B, Financial Advisory, Advanced Materials, Media and Entertainment, Machine Learning, Pharmaceuticals, Risk Management may find it worthwhile to explore potential connections with Jayne Parker, as their portfolio suggests a familiarity and interest in this area.

Understanding Jayne Parker’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.